G. G. Budak Et Al. , "Preclinical toxicity test results of a new antiviral–immune-modulator compound consisting of flavonoid molecules (COVID-19 clinical trial preliminary data)," Open Exploration Publishing , vol.3, pp.1-21, 2022
Budak, G. G. Et Al. 2022. Preclinical toxicity test results of a new antiviral–immune-modulator compound consisting of flavonoid molecules (COVID-19 clinical trial preliminary data). Open Exploration Publishing , vol.3 , 1-21.
Budak, G. G., ÖZKAN, S., BUDAK, M., ŞEKER, T., MERYEMOĞLU, B., Miran, Ş. S., ... ÇAKIR ÇOBAN, C.(2022). Preclinical toxicity test results of a new antiviral–immune-modulator compound consisting of flavonoid molecules (COVID-19 clinical trial preliminary data). Open Exploration Publishing , vol.3, 1-21.
Budak, Gürer Et Al. "Preclinical toxicity test results of a new antiviral–immune-modulator compound consisting of flavonoid molecules (COVID-19 clinical trial preliminary data)," Open Exploration Publishing , vol.3, 1-21, 2022
Budak, Gürer G. Et Al. "Preclinical toxicity test results of a new antiviral–immune-modulator compound consisting of flavonoid molecules (COVID-19 clinical trial preliminary data)." Open Exploration Publishing , vol.3, pp.1-21, 2022
Budak, G. G. Et Al. (2022) . "Preclinical toxicity test results of a new antiviral–immune-modulator compound consisting of flavonoid molecules (COVID-19 clinical trial preliminary data)." Open Exploration Publishing , vol.3, pp.1-21.
@article{article, author={Gürer Güven Budak Et Al. }, title={Preclinical toxicity test results of a new antiviral–immune-modulator compound consisting of flavonoid molecules (COVID-19 clinical trial preliminary data)}, journal={Open Exploration Publishing}, year=2022, pages={1-21} }